In a filing, Standard BioTools Inc revealed its Director Casdin Partners Master Fund, L acquired Company’s shares for reported $3669.0 on Mar 05 ’24. In the deal valued at $2.62 per share,1,403 shares were bought. As a result of this transaction, Casdin Partners Master Fund, L now holds 11,497,928 shares worth roughly $ 28.97 million.
Then, Casdin Partners Master Fund, L bought 250,000 shares, generating $642,500 in total proceeds. Upon buying the shares at $2.57, the Director now owns 11,496,525 shares.
Before that, Casdin Eli bought 800,000 shares. Standard BioTools Inc shares valued at $1,835,920 were divested by the Director at a price of $2.29 per share. As a result of the transaction, Casdin Eli now holds 1,200,000 shares, worth roughly $3.02 million.
TD Cowen initiated its Standard BioTools Inc [LAB] rating to a Buy in a research note published on April 16, 2024; the price target was $3.50. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering LAB with “an Overweight” recommendation on July 12, 2023.
Price Performance Review of LAB
On Friday, Standard BioTools Inc [NASDAQ:LAB] saw its stock fall -0.79% to $2.52. Over the last five days, the stock has lost -9.68%. Standard BioTools Inc shares have risen nearly 14.03% since the year began. Nevertheless, the stocks have risen 42.37% over the past one year. While a 52-week high of $3.16 was reached on 04/09/24, a 52-week low of $1.46 was recorded on 01/05/24. SMA at 50 days reached $2.59, while 200 days put it at $2.42. A total of 2.75 million shares were traded, compared to the trading of 2.83 million shares in the previous session.
Levels Of Support And Resistance For LAB Stock
The 24-hour chart illustrates a support level at 2.47, which if violated will result in even more drops to 2.41. On the upside, there is a resistance level at 2.59. A further resistance level may holdings at 2.65. The Relative Strength Index (RSI) on the 14-day chart is 40.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.86%. Stochastics %K at 6.04% indicates the stock is a buying.
